12 septembre 2018 | International, Aérospatial, Naval, Terrestre, C4ISR

French joint chief calls for coordinated European force

By:

SATORY ARMY BASE, France — Nations in Europe need to forge a more coordinated forceacross the continent, with each ready to step up to play a leadership role during conflict, said the French joint chief of staff.

“The future of the defense of nations on the continent cannot be considered outside the European framework,” Army Gen. François Lecointre told the Summer Defense University, a two-day gathering of senior officers, parliamentarians and industry chiefs.

“In the context of doubt over multilateralism, greater fragility of alliances and America's refocus of attention to the Indo-Pacific region, the European continent must confront — increasingly on its own — all kinds of threats: might, terrorism, hybrid, cyber and migration,” he said.

That use of the term “might” referred to unspecified nations perceived to pose a threat to Western allies.

That calls for a common vision in strategy and capability, with a country ready to take the role of a “leader nation,” he said. The aim is to build a “European strategic autonomy,” he added.

The French armed forces minister, Florence Parly, came to the army base, just outside Versailles, west of the capital, and watched a dynamic display staged by the Army. The service fielded a Jaguar combat and reconnaissance vehicle, a VBCI infantry fighting vehicle carrying a squad of troops, a robotic vehicle carrying a wounded soldier, and a Leclerc main battle tank carried by a tank transport.

France invites foreign officers and political leaders to the high-level annual gathering, organized by CEIS, a think tank and consultancy.

https://www.defensenews.com/global/europe/2018/09/11/french-joint-chief-calls-for-coordinated-european-force

Sur le même sujet

  • India’s new defense budget falls way short for modernization plans

    6 février 2019 | International, Aérospatial, Naval, Terrestre, C4ISR, Sécurité, Autre défense

    India’s new defense budget falls way short for modernization plans

    By: Vivek Raghuvanshi NEW DELHI – India's defense budget for 2019 included a marginal 6.87 percent bump to $49.68 billion, which is unlikely to meet modernization demands or ‘Make in India' manufacturing increases. Out of the total allocation, $16.91 billion has been set aside to buy new weapons and other military hardware, compared to $14.68 billion in the previous financial year. But not accounted for are the liabilities, say some defense analysts, which could chip away at available funds. “As of now, one doesn't know about the extent of committed liabilities to be able to say how much money will be available for new purchases,” said Amit Cowshish, former financial advisor for the Ministry of Defence acquisition. "But it can be said with reasonable certainty that the allocation must be much less than the requirement projected by the ministry. That being the case, the ministry will have to make do with whatever money they have got, just the way they have been managing in the past.” India's defence budget is more than five times that of Pakistan, pegged at $9.6 billion — barely enough to maintain its basic operational capability. Presenting the interim budget for 2019-20 in parliament, Union Minister for Finance and Corporate Affairs Piyush Goyal said additional funds, if necessary, would be provided to secure India's borders and maintain its defense preparedness. Under capital outlay, the Army was granted $4.60 billion and the Navy granted $3.61 billion — both nearly flat compared to the year before. The Indian Air Force was allocated $6.14 billion, combared to $5.58 billion in the previous year. One MoD official said the majority of funds will go towards past committed liabilities for Rafale fighters, S-400 missile systems, warships and helicopters. Still, the fact that the budget saw an increase is noteworthy to some. “The allocation for defense, which for the first time has crossed the $49 billion threshold is encouraging," said Baba Kalyani, chairman of leading private sector defense enterprise Bharat Forge Ltd. In terms of manufacturing, "we hope that ‘Make in India' will result in a greater role for the private industry in this critical sector of the country's economy.” Cowshish is less encouraged, seeing very few noteworthy programs on the horizon. “It doesn't seem likely that many big contracts for fighters, helicopters, submarines, etc. will get concluded in the coming year," he said. "This is not because of paucity of funds but on account of the fact that none of these procurement proposals are likely to reach anywhere near the contract conclusion stage any time soon. “ https://www.defensenews.com/global/asia-pacific/2019/02/05/indias-new-defense-budget-falls-way-short-for-modernization-plans/

  • Here’s who will build the US Army’s new missile defense radar

    17 octobre 2019 | International, Terrestre

    Here’s who will build the US Army’s new missile defense radar

    By: Jen Judson WASHINGTON — Incumbent Raytheon will build the U.S. Army's new missile defense radar to replace the Patriot air and missile defense system's current radar as part of the service's future Integrated Air and Missile Defense System. The company has taken its years of experience refining gallium nitride, or GaN, technology at its Massachusetts-based foundry to help design a new radar system that will provide the Army 360-degree threat detection capability in a configuration that includes one large array in the front and two smaller arrays in the back. The contract is worth roughly $384 million to deliver six production-representative units of the Lower Tier Air and Missile Defense Sensor, or LTAMDS. “Our clean-sheet approach to LTAMDS reinforces Raytheon's position as the world's premier air and missile defense radar capability provider,” Ralph Acaba, president of Raytheon Integrated Defense Systems, said in a statement. The service earlier this year held a “sense-off” at White Sands Missile Range, New Mexico, between three working radars from Raytheon, a Lockheed Martin and Elta Systems team,and Northrop Grumman. The service analyzed the results and was in contract negotiations with the winner as the Association of the U.S. Army's annual conference, which kicked off Oct. 14. Brig. Gen. Brian Gibson, who is in charge of the service's air and missile defense modernization effort, told Defense News in an interview ahead of the show that negotiations were ongoing and that the award would happen soon. Without public knowledge of the win, Raytheon brought its offering for the LTAMDS competition to the show and passed out red lanyards advertising LTAMDS that said: “No time for a blind spot,” referring to the 360-degree coverage capability. Replacing the Patriot radar has been a long time coming. The radar was first fielded in the 1980s, and the Army previously attempted to replace the system with Lockheed Martin's Medium Extended Air Defense System through an international co-development effort with Germany and Italy. But that program was canceled in the U.S. after closing out a proof-of-concept phase roughly six years ago. Since then, the Army studied and debated how to replace the Patriot radar, while Raytheon continued to upgrade its radar to keep pace with current threats. The service has acknowledged there will come a point where radar upgrades will be unable to keep up with future threats. Taking years to decide, the service moved forward on a competition to replace the radar in 2017 and chose four companies to come up with design concepts for the capability — Raytheon, Lockheed Martin, Northrop Grumman and Technovative Applications. Toward the end of 2018, Raytheon and Lockheed were chosen to continue technology development under that program. But then the Army redirected its plans into a sense-off competition last fall. Raytheon is expected to build six prototypes by the end of fiscal 2022. The radar that Raytheon specifically designed for the Army uses next-generation GaN and is 7 feet longer but 11 inches more narrow than the current radar unit. But it no longer requires outrigger stabilizing legs. Rather, the system is held stable by jacks underneath, which means it takes up less space on the sides, according to Bob Kelley, Raytheon's director of domestic integrated air and missile defense programs for business development and strategy. The radar meets all of the Army's mobility and transport requirements, Kelley said, including fitting in a C-17 aircraft. The smaller arrays are about 50 percent of the size of the legacy Patriot system's array, but are twice as capable due to the advancements with GaN technology, he added. Though the Army backed off its 360-degree detection capability requirement for the competition, Raytheon has been steadfast about keeping that capability in its offering. In addition to being able to constantly cover 360 degrees, the radar can see farther than the currently fielded Patriot radar. That radar is unable to fully support the maximum kinematic range of the Patriot Advanced Capability-3 Missile Segment Enhancement that it fires. The Army claims that its effort to tie the Terminal High Altitude Area Defense System with Patriot would help the MSE missile reach its full potential. The LTAMDS will be able to fully support current missile systems including PAC-3 MSE range capability and future missiles ranges, Kelley said. https://www.defensenews.com/breaking-news/2019/10/17/heres-who-will-build-the-armys-new-missile-defense-radar

  • A New Layer of Medical Preparedness to Combat Emerging Infectious Disease

    25 février 2019 | International, Autre défense

    A New Layer of Medical Preparedness to Combat Emerging Infectious Disease

    DARPA has selected five teams of researchers to support PREventing EMerging Pathogenic Threats (PREEMPT), a 3.5-year program first announced in January 2018 to reinforce traditional medical preparedness by containing viral infectious diseases in animal reservoirs and insect vectors before they can threaten humans. Through studies in secure laboratories and simulated natural environments, the PREEMPT researchers will model how viruses might evolve within animal populations, and assess the safety and efficacy of potential interventions. Autonomous Therapeutics, Inc., Institut Pasteur, Montana State University, The Pirbright Institute, and the University of California, Davis, lead the PREEMPT teams. “DARPA challenges the PREEMPT research community to look far left on the emerging threat timeline and identify opportunities to contain viruses before they ever endanger humans,” said Dr. Brad Ringeisen, the DARPA program manager for PREEMPT. “One of the chief limitations of how infectious disease modeling is currently conducted is that it forecasts the trajectory of an outbreak only after it is underway in people. The best that data can do is inform a public health response, which places the United States in a reactive mode. We require proactive options to keep our troops and the homeland safe from emerging infectious disease threats.” According to the World Health Organization (WHO), approximately 60 percent of emerging infectious diseases reported globally are zoonoses, meaning that they were initially diseases of animals and at some point became capable of infecting people. Zoonotic diseases are responsible for millions of human deaths every year, and the scope of the challenge is increasing due to the densification of livestock production, human encroachment into natural spaces, and upward trends in globalization, temperature, and population. Ebola is a high-profile example of a zoonotic disease. Despite being relatively difficult to spread — requiring direct contact with fluids from infected organisms — a string of outbreaks over the past five years has highlighted the threat it could present once established in densely populated areas. Researchers express even greater concern over the pandemic potential of new strains of the influenza virus and other airborne pathogens. Even in the United States and its territories, where viruses do not frequently emerge directly from animal reservoirs, vector-borne transmission of zoonoses such as West Nile virus disease is on the rise. The 2018 U.S. National Biodefense Strategy directs that it is essential to detect and contain such bio-threats, adopting a proactive posture to improve preparedness while also assessing and managing any biosecurity risks related to possible interventions. “The health of the American people depends on our ability to stem infectious disease outbreaks at their source, wherever and however they occur,” the document states. For the Department of Defense, that obligation extends to protection of deployed service members, who often operate in countries that are “hot spots” for emerging viruses yet lack robust public health infrastructure. The teams DARPA selected for PREEMPT comprise multidisciplinary researchers who bring expertise and field experience from around the world, some of whom represent institutions from nations at high risk from emerging infectious disease. Institutions participating as sub-contractors to DARPA receive funding from the lead organizations except as otherwise noted. The PREEMPT teams proposed to model specific diseases to assess the risk of spillover from animals into humans, identify key bottlenecks in the process as opportunities for intervention, and develop and assess novel, animal- or insect-focused interventions with built-in safety switches to prevent cross-species jump. The teams will collect samples from animal reservoirs in the field for analysis in secure, bio-contained facilities; some teams will also conduct analysis on existing banked samples and datasets. DARPA is not funding the release of PREEMPT interventions into the environment. Autonomous Therapeutics, Inc., under principal investigator Dr. Ariel Weinberger, leads a team made up of CSIRO Australian Animal Health Laboratory; Navy Medical Research Unit-2, funded directly by DARPA; University of California, Los Angeles; University of Chicago Medical School; and University of Texas Medical Branch. The team will study air-borne highly pathogenic avian influenza virus in birds and small mammals, and tick-borne Crimean-Congo hemorrhagic fever virus. The Center for Comparative Medicine and the One Health Institute at the University of California, Davis, under principal investigator Dr. Peter Barry and co-PI Dr. Brian Bird, respectively, lead a team made up of the Leibniz Institute for Experimental Virology; Mount Sinai School of Medicine; Rocky Mountain Laboratories of the National Institutes of Health (NIH), to be funded directly by DARPA; The Vaccine Group, Ltd., a spin-out of University of Plymouth; University of Glasgow; University of Idaho; and University of Western Australia. The team will examine Lassa virus spillover from rodents, and study Ebola virus in rhesus macaques. The Institut Pasteur, under principal investigator Dr. Carla Saleh, leads a team made up of Institut Pasteur International Network partners in Cambodia, Central African Republic, France, French Guiana, Madagascar, and Uruguay; Latham BioPharm Group; and Virginia Polytechnic Institute and State University. The team will study several mosquito-borne arboviruses, which refers broadly to animal or human viruses transmitted by insects, as well as mosquito-specific viruses that could interfere with arbovirus infection in the insect vector. Montana State University, under principal investigator Dr. Raina Plowright, leads a team made up of the Cary Institute of Ecosystem Studies; Colorado State University; Cornell University; Griffith University; Johns Hopkins University; NIH's Rocky Mountain Laboratories, funded directly by DARPA; Pennsylvania State University; Texas Tech University; University of California, Berkeley; University of California, Los Angeles; and University of Cambridge. The team will study henipavirus spillover from bats. The henipavirus genus of viruses contains multiple biothreat agents as categorized by NIH and the Centers for Disease Control and Prevention (CDC). The Pirbright Institute, under principal investigator Dr. Luke Alphey, leads a team made up of the University of Nottingham and the University of Tartu. The team seeks to disrupt mosquito transmission of flaviviruses, which include Dengue fever, West Nile, and Zika viruses. Modeling and quantification are as important as new experimental technologies in preventing cross-species jumps. The results from modeling will inform when, where, and at what levels such interventions could be applied to achieve the greatest health benefits. Interventions under consideration include animal- or insect-targeted vaccines, therapeutic interfering particles, gene editors, and indirect approaches informed by environmental and ecological factors that affect how viruses are spread — for instance, understanding the environmental stressors that drive bats into closer contact with humans and devising mitigating options to reduce the likelihood of that contact. The research teams' approaches each come with a unique set of potential benefits and challenges, and the teams are responsible for assessing and demonstrating to DARPA the safety, efficacy, stability, and controllability of their proposed interventions. In the future, these considerations could factor into decisions by the ultimate end users — communities, governments, and regulators — on which strategies to pursue to prevent new zoonoses. DARPA and the PREEMPT teams receive guidance from independent expert advisors in the ethical, legal, social, and regulatory aspects of the life sciences. These individuals include Dr. Claudia Emerson, director of the Institute on Ethics & Policy for Innovation at McMaster University; Dr. Matt Kasper, legislative liaison for the U.S. Navy's Bureau of Medicine and Surgery, and a former deputy director of field laboratory operations at the Naval Medical Research Center; and Dr. Steve Monroe, associate director for Laboratory Science and Safety at the CDC, and a former deputy director of the CDC's National Center for Emerging and Zoonotic Infectious Diseases. The teams also benefit from established relationships with local universities, communities, and governments based on prior or ongoing research. These relationships will facilitate initial field collection and help to familiarize stakeholders with PREEMPT technologies as they are being developed. DARPA is also beginning outreach to the WHO as a potential avenue for future transition of PREEMPT technologies. DARPA intends that PREEMPT teams will perform fundamental research and publish results for review by the broader scientific community. https://www.darpa.mil/news-events/2019-02-19

Toutes les nouvelles